Parel, Mumbai, Maharashtra
GST No. 27AADFE3806H1ZN
Call 07942871807 81% Response Rate
Strength | 250 mg |
Packaging Type | Box |
Brand | Geftinat |
Manufactured By | Natco |
Medicine Type | Allopathic |
Form | Tablets |
Packing Size | 30 Tablets |
View Complete details
Strength | 250 mg |
Packaging Type | Box |
Brand | Geftinat |
Manufactured By | Natco |
Medicine Type | Allopathic |
Form | Tablets |
Packing Size | 30 Tablets |
View Complete details
Strength | 250 mg |
Packaging Type | Box |
Brand | Geftinat |
Manufactured By | Natco |
Medicine Type | Allopathic |
Form | Tablets |
Packing Size | 30 Tablets |
Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.
View Complete details
Strength | 250 mg |
Packaging Type | Box |
Brand | Geftinat |
Manufactured By | Natco |
Medicine Type | Allopathic |
Form | Tablets |
Packing Size | 30 Tablets |
View Complete details
Strength | 250 mg |
Packaging Type | Box |
Brand | Geftinat |
Manufactured By | Natco |
Form | Tablets |
Packing Size | 30 Tablets |
Medicine Type | Allopathic |
Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.
View Complete details
Strength | 250 mg |
Packaging Type | Box |
Brand | Geftinat |
Manufactured By | Natco |
Medicine Type | Allopathic |
Form | Tablets |
Packing Size | 30 Tablets |
View Complete details
Minimum Order Quantity: 1 Box
Product Brochure
Dose/Strength | 250 mg |
Packaging Size | 1*10 Tablets |
Brand | Cipla |
Usage/Application | Commercial |
Manufacturer | Cipla |
Shelf Life | 2 Years |
Packaging Type | Stripe |
Additional Information:
View Complete details